Pharma Surge

Pharma Surge

🇬🇧·1d agoResearch

Efficacy, safety, and acceptability of a child-friendly, chewable formulation of oxantel pamoate versus mebendazole for Trichuris spp infections in children aged 2-12 years in Tanzania: a randomised, single-blind, phase 2 trial

Publisher

P
PubMed Lancet Infectious Diseases RSS

UK

This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.

Read original

At a glance

Publisher
PubMed Lancet Infectious Diseases RSS
Region
UK
Scope
Research
Published
July 22, 2026
Language
EN

Topics

journal

In-platform summary, original article off-platform

This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.

Source route

Continue on pubmed.ncbi.nlm.nih.gov

Leave the platform to read the original full article on the publisher site.

Source: PubMed Lancet Infectious Diseases RSS

Scope: Research

Open original article
Efficacy, safety, and acceptability of a child-friendly, chewable formulation of oxantel pamoate versus mebendazole for Trichuris spp infections in children aged 2-12 years in Tanzania: a randomised, single-blind, phase 2 trial | Pharma Surge